BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sabater-Molina M, Navarro-Peñalver M, Muñoz-Esparza C, Esteban-Gil Á, Santos-Mateo JJ, Gimeno JR. Genetic Factors Involved in Cardiomyopathies and in Cancer. J Clin Med 2020;9:E1702. [PMID: 32498335 DOI: 10.3390/jcm9061702] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ricci F, Banihashemi B, Pirouzifard M, Sundquist J, Sundquist K, Sutton R, Fedorowski A, Zöller B. Familial risk of dilated and hypertrophic cardiomyopathy: a national family study in Sweden. ESC Heart Fail 2022. [PMID: 36169166 DOI: 10.1002/ehf2.14171] [Reference Citation Analysis]
2 Gandaeva LA, Basargina EN, Kondakova OB, Kaverina VG, Pushkov AA, Zharova OP, Fisenko PP, Savostyanov KV. A new nucleotide variant in the <I>ELAC2</I> gene in a young child with a ventricular hypertrophy. Ross vestn perinatol pediatr 2022;67:120-126. [DOI: 10.21508/1027-4065-2022-67-4-120-126] [Reference Citation Analysis]
3 Guler MN, Tscheiller NM, Sabater-molina M, Gimeno JR, Nebigil CG. Evidence for reciprocal network interactions between injured hearts and cancer. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.929259] [Reference Citation Analysis]
4 Wang Y, Wang Y, Han X, Sun J, Li C, Adhikari BK, Zhang J, Miao X, Chen Z. Cardio-Oncology: A Myriad of Relationships Between Cardiovascular Disease and Cancer. Front Cardiovasc Med 2022;9:727487. [DOI: 10.3389/fcvm.2022.727487] [Cited by in F6Publishing: 1] [Reference Citation Analysis]